Correlations between kynurenines in plasma and CSF, and their relation to markers of Alzheimer's disease pathology

被引:15
作者
Bakker, Lieke [1 ,2 ,3 ]
Kohler, Sebastian [1 ,2 ,3 ]
Eussen, Simone J. P. M. [4 ,5 ,6 ]
Choe, Kyonghwan [1 ,2 ,3 ,9 ]
van den Hove, Daniel L. A. [2 ,3 ,7 ]
Kenis, Gunter [1 ,2 ,3 ]
Rutten, Bart P. F. [1 ,2 ,3 ]
Ulvik, Arve [8 ]
Ueland, Per M. [8 ]
Verhey, Frans R. J. [1 ,2 ,3 ]
Ramakers, Inez H. G. B. [1 ,2 ,3 ]
机构
[1] Maastricht Univ, Alzheimer Ctr Limburg, NL-6229 ET Maastricht, Netherlands
[2] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNs, NL-6229 ER Maastricht, Netherlands
[3] Maastricht Univ, European Grad Sch Neurosci EURON, NL-6229 ER Maastricht, Netherlands
[4] Maastricht Univ, Dept Epidemiol, NL-6229 HA Maastricht, Netherlands
[5] Maastricht Univ, Sch Cardiovasc Dis CARIM, NL-6229 ER Maastricht, Netherlands
[6] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, NL-6229 ER Maastricht, Netherlands
[7] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97080 Wurzburg, Germany
[8] BEVITAL, N-5021 Bergen, Norway
[9] Gyeongsang Natl Univ, Div Life Sci & Appl Life Sci, Coll Nat Sci, Jinju 52828, South Korea
关键词
Kynurenine pathway; Kynurenines; Plasma; CSF; Alzheimer 's disease; Amyloid-beta; Phosphorylated-tau; Neuroprotective; Neurotoxic; Cognitive impairment; QUINOLINIC ACID LEVELS; CEREBROSPINAL-FLUID; PATHWAY METABOLITES; BRAIN; DEMENTIA; INFLAMMATION; BIOMARKERS; INFECTION; TRANSPORT; SERUM;
D O I
10.1016/j.bbi.2023.04.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Altered levels of kynurenines in blood and cerebrospinal fluid (CSF) have been reported in Alz-heimer's disease (AD). However, it is still largely unknown whether peripheral kynurenine concentrations resemble those found in CSF and how they relate to AD pathology. We therefore studied correlations between kynurenines in plasma and CSF and their associations with CSF amyloid-beta (A beta 1-42) and tau levels in patients from the memory clinic spanning the whole cognitive spectrum.Methods: The Biobank Alzheimer Center Limburg study is a prospective cohort study of consecutive patients referred to the memory clinic of the Alzheimer Center Limburg. Plasma and CSF concentrations of tryptophan (TRP), eight kynurenines and neopterin from 138 patients were determined by means of LC-MS/MS. Addition-ally, CSF A beta 1-42, total-tau (t-tau) and phosphorylated tau (p-tau) concentrations were determined using commercially available single-parameter ELISA methods. Partial correlations were used to analyze cross-sectional associations between kynurenines in plasma and CSF and their relation to AD related CSF-biomarkers adjusted for age, sex, educational level, and kidney function.Results: Moderate to strong correlations were observed between plasma and CSF levels for quinolinic acid (QA; r = 0.63), TRP (r = 0.47), anthranilic acid (r = 0.59), picolinic acid (r = 0.55), and the kynurenine (KYN)/TRP ratio (KTR; r = 0.55; all p < 0.0001), while other kynurenines correlated only weakly with their corresponding CSF values. No correlations were found between plasma and CSF levels of KA/QA. Several kynurenines were also weakly correlated with A beta 1-42, t-tau or p-tau. Plasma levels of KA/QA were negatively correlated with A beta 1-42 (r =-0.21, p < 0.05). Plasma levels of TRP were negatively correlated with t-tau (r =-0.19) and levels of KYN with p -tau (r =-0.18; both p < 0.05). CSF levels of KYN (r = 0.20, p < 0.05), KA (r = 0.23, p < 0.01), and KTR (r = 0.18, p < 0.05) were positively correlated with A beta 1-42. Finally, TRP and KYN were negatively (r =-0.22 and r =-0.18, respectively), and neopterin positively (r = 0.19) correlated with p-tau (all p < 0.05). Conclusions: Plasma concentrations of TRP, KP metabolites, KTR, and neopterin all significantly correlated positively with their corresponding CSF concentrations, but many correlations were weak. Additionally, our results suggest a relation between higher kynurenine levels and lower AD pathology load. These results need verification in future studies and require more research into (shared) underlying mechanisms.
引用
收藏
页码:312 / 319
页数:8
相关论文
共 61 条
[1]   Associations between plasma kynurenines and cognitive function in individuals with normal glucose metabolism, prediabetes and type 2 diabetes: the Maastricht Study [J].
Bakker, Lieke ;
Ramakers, Inez H. G. B. ;
van Boxtel, Martin P. J. ;
Schram, Miranda T. ;
Stehouwer, Coen D. A. ;
van der Kallen, Carla J. H. ;
Dagnelie, Pieter C. ;
van Greevenbroek, Marleen M. J. ;
Wesselius, Anke ;
Midttun, Oivind ;
Ueland, Per M. ;
Verhey, Frans R. J. ;
Eussen, Simone J. P. M. ;
Kohler, Sebastian .
DIABETOLOGIA, 2021, 64 (11) :2445-2457
[2]   Accumulation of pathological tau species and memory loss in a conditional model of tauopathy [J].
Berger, Zdenek ;
Roder, Hanno ;
Hanna, Amanda ;
Carlson, Aaron ;
Rangachari, Vijayaraghavan ;
Yue, Mei ;
Wszolek, Zbigniew ;
Ashe, Karen ;
Knight, Joshua ;
Dickson, Dennis ;
Andorfer, Cathy ;
Rosenberry, Terrone L. ;
Lewis, Jada ;
Hutton, Mike ;
Janus, Christopher .
JOURNAL OF NEUROSCIENCE, 2007, 27 (14) :3650-3662
[3]   Cerebrospinal fluid and plasma biomarkers in Alzheimer disease [J].
Blennow, Kaj ;
Hampel, Harald ;
Weiner, Michael ;
Zetterberg, Henrik .
NATURE REVIEWS NEUROLOGY, 2010, 6 (03) :131-144
[4]   Indoleamine 2,3-dioxygenase and 3-hydroxy-kynurenine modifications are found in the neuropathology of Alzheimer's disease [J].
Bonda, David J. ;
Mailankot, Maneesh ;
Stone, Jeremy G. ;
Garrett, Matthew R. ;
Staniszewska, Magdalena ;
Castellani, Rudy J. ;
Siedlak, Sandra L. ;
Zhu, Xiongwei ;
Lee, Hyoung-gon ;
Perry, George ;
Nagaraj, Ram H. ;
Smith, Mark A. .
REDOX REPORT, 2010, 15 (04) :161-168
[5]   Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus [J].
Carrillo-Mora, Paul ;
Mendez-Cuesta, Luis A. ;
Perez-De la Cruz, Veronica ;
Fortoul-van Der Goes, Teresa I. ;
Santamaria, Abel .
BEHAVIOURAL BRAIN RESEARCH, 2010, 210 (02) :240-250
[6]   Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health [J].
Cervenka, Igor ;
Agudelo, Leandro Z. ;
Ruas, Jorge L. .
SCIENCE, 2017, 357 (6349)
[7]   Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β [J].
Cespedes, Marcela ;
Jacobs, Kelly R. ;
Maruff, Paul ;
Rembach, Alan ;
Fowler, Christopher J. ;
Trounson, Brett ;
Pertile, Kelly K. ;
Rumble, Rebecca L. ;
Rainey-Smithe, Stephanie R. ;
Rowe, Christopher C. ;
Villemagne, Victor L. ;
Bourgeat, Pierrick ;
Lim, Chai K. ;
Chatterjee, Pratishtha ;
Martins, Ralph N. ;
Ittner, Arne ;
Masters, Colin L. ;
Doecke, James D. ;
Guillemin, Gilles J. ;
Lovejoy, David B. .
NEUROBIOLOGY OF DISEASE, 2022, 171
[8]   Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease [J].
Chatterjee, Pratishtha ;
Zetterberg, Henrik ;
Goozee, Kathryn ;
Lim, Chai K. ;
Jacobs, Kelly R. ;
Ashton, Nicholas J. ;
Hye, Abdul ;
Pedrini, Steve ;
Sohrabi, Hamid R. ;
Shah, Tejal ;
Asih, Prita R. ;
Dave, Preeti ;
Shen, Kaikai ;
Taddei, Kevin ;
Lovejoy, David B. ;
Guillemin, Gilles J. ;
Blennow, Kaj ;
Martins, Ralph N. .
JOURNAL OF NEUROINFLAMMATION, 2019, 16 (01)
[9]   Longitudinal plasma metabolomics of aging and sex [J].
Darst, Burcu F. ;
Koscik, Rebecca L. ;
Hogan, Kirk J. ;
Johnson, Sterling C. ;
Engelman, Corinne D. .
AGING-US, 2019, 11 (04) :1262-1282
[10]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198